authorities have started to crack down: FDA Warning on Safety Risks: In late 2023, the FDA explicitly flagged BPC-157 as an unsafe compound to use in compounding
Reconstituted liquid: Must be stored in a refrigerator (2C to 8C)
Exposure to low BPA at 72 hpf, when the retina has formed 44 and is becoming functional 43 , initially affects eye size, retinal layering and optomotor responses 42
Accordingly, NaBPC157 can be used to initiate and support healing processes, in particular wound and/or ulcer healing processes
Sept 20: The FDA surprised ARS Pharmaceuticalsif the tone of the companys press release is any indicationby issuing a Complete Response Letter for neffy, an epinephrine nasal spray, in type 1 allergic reactions, including anaphylaxis